<DOC>
	<DOC>NCT01949766</DOC>
	<brief_summary>This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.</brief_summary>
	<brief_title>Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis, Intrahepatic</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>Byler Disease Cholestasis Tolerance of Buphenyl therapy Allergy/Hypersensitivity to RAVICTI</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>